2nd Annual Cancer Immunotherapy Summit 2017

The 2nd Annual Cancer Immunotherapy Summit 2017 covers topics such as:

• The success of antibodies in therapeutics and engineering
• Advanced methods, technological developments and strategies in Cancer Immunotherapy
• Revolutionary cancer treatment with personalised cancer vaccines
• The true potential of the next generation immune checkpoint pathways
• Biomarkers’ responses
• Reinforcing anti-tumour immunity
• Progressive genetic engineering techniques
• Managing unique immune-mediated adverse reactions and toxicity effects
• CAR T-Cell Therapy: A game changer in cancer treatment
• Preclinical and clinical progress in Cancer Immunotherapy
• Regulatory aspects of the EU and the rest of the world

The 2nd Annual Cancer Immunotherapy Summit 2017 brings together attendees involved or interested in:

• Clinical Diagnostics
• Oncology
• Drug Delivery
• Drug Discovery
• Antibody Discovery
• Antibody Engineering
• Immuno-Oncology
• Cancer Immunotherapy
• Translational Medicine Genetics and Genomics
• Hematology
• Bioinformatics
• Infection and Immunity
• Cancer Genomics
• Cell & Gene Therapy
• Cell Therapy Research
• Tumour Immunology
• Preclinical Development
• Vaccines Development
• Pathology